This combination of photos shows Russian President Vladimir Putin, left, in Moscow on 9 May 2025, and President Donald Trump in Washington on 1 August.

Tirzepatide (GIP + GLP-1) has also been shown to reduce cardiovascular risk. In an international trial of 713 adults in nine ...